[go: up one dir, main page]

ES2061989T3 - Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis. - Google Patents

Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.

Info

Publication number
ES2061989T3
ES2061989T3 ES89304842T ES89304842T ES2061989T3 ES 2061989 T3 ES2061989 T3 ES 2061989T3 ES 89304842 T ES89304842 T ES 89304842T ES 89304842 T ES89304842 T ES 89304842T ES 2061989 T3 ES2061989 T3 ES 2061989T3
Authority
ES
Spain
Prior art keywords
treatment
pyroglutamic acid
ictiosis
manufacture
alkyl esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89304842T
Other languages
English (en)
Inventor
Ian Richard Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2061989T3 publication Critical patent/ES2061989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA COMPOSICION TERAPEUTICA PARA EL TRATAMIENTO DE ALTERACIONES DE LA PIEL COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UN AGENTE CURATIVO ELEGIDO DE ESTERES ESPECIALES DE ACIDO PIROGLUTAMICO Y MEZCLAS DE ESTO, EN UN VEHICULO ACEPTABLE TERAPEUTICAMENTE PARA APLICACION TOPICA.
ES89304842T 1988-05-13 1989-05-12 Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis. Expired - Lifetime ES2061989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811410A GB8811410D0 (en) 1988-05-13 1988-05-13 Treatment of skin disorders

Publications (1)

Publication Number Publication Date
ES2061989T3 true ES2061989T3 (es) 1994-12-16

Family

ID=10636883

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89304842T Expired - Lifetime ES2061989T3 (es) 1988-05-13 1989-05-12 Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.

Country Status (10)

Country Link
US (1) US5045559A (es)
EP (1) EP0342055B1 (es)
JP (1) JPH0217122A (es)
AT (1) ATE99932T1 (es)
AU (1) AU617466B2 (es)
CA (1) CA1324760C (es)
DE (1) DE68912195T2 (es)
ES (1) ES2061989T3 (es)
GB (1) GB8811410D0 (es)
ZA (1) ZA893563B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016351C (en) * 1989-05-12 1996-09-03 Walter Thomas Gibson Cosmetic composition
US5455036A (en) * 1990-06-29 1995-10-03 Bode Chemie Method of using cis-urocaninic acid for topically treating psoriasis
US5286720A (en) * 1992-07-16 1994-02-15 Solarcare Technologies Corporation Compositions and methods for topical treatment of skin lesions
GB2313059B (en) * 1993-03-29 1998-01-21 Bioglan Ireland Pharmaceutically useful pyrrolyl derivatives
US5624915A (en) * 1993-08-04 1997-04-29 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
CA2823407C (en) * 2007-03-22 2016-10-18 Berg Pharma Llc Topical formulations having enhanced bioavailability
JP5352100B2 (ja) * 2008-03-12 2013-11-27 株式会社 資生堂 皮膚外用組成物
ES2336995B1 (es) * 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US10519504B2 (en) 2009-05-11 2019-12-31 Berg Llc Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
WO2011014244A1 (en) 2009-07-28 2011-02-03 St. Jude Medical Puerto Rico Llc Vascular closure device with automatic suture cutter
US11400058B2 (en) * 2010-03-12 2022-08-02 Berg Llc Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof
US8846723B2 (en) * 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
US8329938B2 (en) 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235457A (en) * 1962-12-07 1966-02-15 Gillette Co Humectant
DE2102172C3 (de) * 1971-01-18 1980-03-20 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mittel zur Behandlung und Pflege der Haut
DE2102171A1 (en) * 1971-01-18 1972-07-27 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidonecarboxylic acid alkyl esters - cosmetic agents
JPS4882046A (es) * 1972-02-02 1973-11-02
JPS536217B2 (es) * 1972-11-30 1978-03-06
LU74438A1 (es) * 1976-02-26 1977-09-12
JPS57185209A (en) * 1981-05-11 1982-11-15 Nisshin Oil Mills Ltd:The Esterified composition and cosmetic containing the same
JPS60214744A (ja) * 1984-04-06 1985-10-28 Nitto Electric Ind Co Ltd 薬物の経皮吸収促進助剤及びこれを含有する外用医薬組成物
GB8421112D0 (en) * 1984-08-20 1984-09-26 Unilever Plc Pyroglutamic acid esters
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use

Also Published As

Publication number Publication date
AU3459689A (en) 1989-11-16
GB8811410D0 (en) 1988-06-15
CA1324760C (en) 1993-11-30
EP0342055A2 (en) 1989-11-15
ATE99932T1 (de) 1994-01-15
ZA893563B (en) 1991-01-30
US5045559A (en) 1991-09-03
AU617466B2 (en) 1991-11-28
EP0342055B1 (en) 1994-01-12
JPH0217122A (ja) 1990-01-22
DE68912195D1 (de) 1994-02-24
DE68912195T2 (de) 1994-05-19
EP0342055A3 (en) 1990-08-29

Similar Documents

Publication Publication Date Title
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
ATE144414T1 (de) Felbinac enthaltendes arzneimittel
EP0391905A4 (en) Hemorrhoidal, other compositions and methods of treatment
ES2090317T3 (es) Uso del acido 3-guanidinopropionico en la fabricacion de un medicamento para el tratamiento y prevencion del exceso de adiposidad.
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
EP0357030A3 (en) Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
NZ219374A (en) Topical pharmaceutical containing tamoxifen
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
EP0214254A1 (en) MELATONIN COMPOSITIONS AND USES THEREOF.
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
KR910005858A (ko) 지방산 요법
ATE143276T1 (de) Transdermales system mit gestufter wirkstoffabgabe und verwendung für die lokale oder systemische, kosmetische wirkstoffverabreichung
WO1993017691A3 (en) Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
IE870577L (en) Topical amide preparation
NO994630L (no) Metoder for behandling av vaskulaere sykdommer
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 342055

Country of ref document: ES